Influenza [IDSA]

Influenza

IDSA Healthcare Associated Infections GUIDELINES App brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/240694

Contents of this Issue

Navigation

Page 4 of 13

Table 2. Influenza Testing Methods (all A-II) Test Description Methods RT-PCR Time to Results Conventional gel-based real≥2 h time RT-PCR Multiplex PCR Immunoflourescencea DFA staining 2–4 h •  Detects and distinguishes between influenza A and B •  Detects and distinguishes between influenza (A and B) and other respiratory viruses IFA staining •  Detects and distinguishes between influenza A and B •  Detects and distinguishes between influenza (A and B) and other respiratory viruses Rapid influenza Antigen detection: enzyme 10–20 immunoassay diagnostic testsb min •  Detects influenza A only •  Detects, but does not distinguish between, influenza A and B •  Detects and distinguishes between influenza A and B Neuraminidase detection assay 20–30 •  Detects, but does not min distinguish between, influenza A and B Viral culture Shell vial culture 48–72 h Isolation in cell culture 3–10 d Serologyc Hemagglutinin inhibition ELISA Complement-fixation Neutralization Comment High sensitivity, very high specificity; highly recommended Moderately high sensitivity, high specificity; recommended Low to moderate sensitivity, high specificity; limitations should be recognized to interpret results Moderately high sensitivity, highest specificity; important for confirming screening test results and for public health surveillance, but not useful for timely clinical management Available only in reference laboratories, not useful for timely clinical management; recommended only for retrospective diagnosis, surveillance, or research purposes DFA, direct fluorescent antibody; ELISA, enzyme-linked immunosorbent assay; IFA, indirect fluorescent antibody; RT-PCR, reverse transcriptase polymerase chain reaction. a Requires fluorescence microscope. b Includes moderately complex and Clinical Laboratory Improvement Amendments (CLIA)-waived tests. c Usually requires paired acute and convalescent sera. 3

Articles in this issue

Archives of this issue

view archives of Influenza [IDSA] - Influenza